Michael Wetherell
About Michael Wetherell
Michael Wetherell is the Executive Director of Strategy & Business Operations at Bristol-Myers Squibb, with over 20 years of experience in the biopharmaceutical industry.
Executive Director at Bristol-Myers Squibb
Michael Wetherell is currently serving as the Executive Director, Strategy & Business Operations at Bristol-Myers Squibb in New Brunswick, New Jersey. He stepped into this role in December 2019, where he leads the Strategy & Business Operations for the Global Quality organization.
Previous Roles at Bristol-Myers Squibb
Michael Wetherell has held several key positions at Bristol-Myers Squibb prior to his current role. He served as Director, Analytical & Business Operations from 2017 to 2019 in Syracuse, New York. He also held the role of Director, Analytical CMC Strategy for four years from 2013 to 2017. Earlier, he was the Director, External Manufacturing from 2011 to 2013, and Associate Director, QC from 2009 to 2011. He started his time at Bristol-Myers Squibb as Manager/Sr. Scientist from 2005 to 2009.
Experience at Other Organizations
Before joining Bristol-Myers Squibb, Michael Wetherell worked at Genencor, A Danisco Division in Rochester, New York, as a Manager/Scientist from 2003 to 2005. He also spent six years at Wyeth Vaccines Research in Rochester, New York, where he was the Core Facility Lead/Research Scientist III from 1997 to 2003.
Educational Background
Michael Wetherell holds a Master's degree in Biochemistry from the Rochester Institute of Technology, where he studied from 1995 to 1997. He also holds a Bachelor's degree in Chemistry/Biology from the University at Buffalo, achieved between 1987 and 1991.
Over 20 Years in the Biopharmaceutical Industry
With over 20 years of experience in the biopharmaceutical industry, Michael Wetherell has played significant roles focusing on discovery, development, and manufacturing. His extensive career includes leadership positions and a strong background in various aspects of business operations and analytical strategy.